Compare ALKS & ITRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | ITRI |
|---|---|---|
| Founded | 1987 | 1977 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.4B |
| IPO Year | 1991 | 1993 |
| Metric | ALKS | ITRI |
|---|---|---|
| Price | $28.01 | $94.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $42.85 | ★ $136.50 |
| AVG Volume (30 Days) | ★ 1.8M | 634.6K |
| Earning Date | 10-28-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.44 | ★ 14.43 |
| EPS | 2.02 | ★ 5.57 |
| Revenue | $1,521,338,000.00 | ★ $2,408,401,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24.22 | $3.62 |
| P/E Ratio | ★ $13.91 | $17.11 |
| Revenue Growth | ★ 1.08 | 0.14 |
| 52 Week Low | $25.17 | $90.11 |
| 52 Week High | $36.45 | $142.00 |
| Indicator | ALKS | ITRI |
|---|---|---|
| Relative Strength Index (RSI) | 39.96 | 34.29 |
| Support Level | $27.53 | $94.83 |
| Resistance Level | $29.35 | $99.23 |
| Average True Range (ATR) | 0.85 | 2.24 |
| MACD | -0.07 | 0.61 |
| Stochastic Oscillator | 17.59 | 2.45 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.